• 1
    Dienstag JL. Non-A, non-B hepatitis. 1. Recognition, epidemiology, and clinical features. Gastroenterology 1983; 85: 439462.
  • 2
    Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E, Hadler S, Margolis HS. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989; 262: 12011205.
  • 3
    Everhart JE, Di Bisceglie AM, Murray L, Alter HJ, Kuo G, Hoofnagle JH. Risk of non-A, non-B (type C) hepatitis through sexual household contact. Ann Intern Med 1990; 112: 544545.
  • 4
    Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984; 101: 733738.
  • 5
    Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488495.
  • 6
    Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of the cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 1989; 244: 359362.
  • 7
    Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362364.
  • 8
    Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 14941500.
  • 9
    Purcell RH, Hoofnagle JH, Ticehurst J, Gerin JL. Hepatitis viruses. In: SchmidtNJ, EmmonsRW, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. Washington DC: American Public Health Association, 1989; 9571065.
  • 10
    Knodell RG, Ishak KG, Black WL, Chen TS, Craig R, Kaplowitz N, Kiernan TW. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981; 1: 4315.
  • 11
    Good IJ. On the weighted combination of significance tests. J R Statist Soc 1955;Series B, 17: 264265.
  • 12
    Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989; 97: 15591561.
  • 13
    Stevens CE, Taylor PE, Pindyck J, Choo Q-L, Bradley DW, Kuo G, Houghton M. Epidemiology of hepatitis C virus: a preliminary study in volunteer blood donors. JAMA 1990; 263: 4953.
  • 14
    Fattovich G, Tagger A, Brollo L, Pontisso P, Realdi G, Ferroni P, Alberti A. Liver disease in anti-HBe positive chronic HBsAg carriers and hepatitis C virus. Lancet 1989; 2: 797798.
  • 15
    McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result. Lancet 1990; 335: 754757.
  • 16
    Eberling F, Naukkarinen R, Leikola J. Recombinant immunoblot assay for hepatitis C antibody as predictor of infectivity. Lancet 1990; 335: 982983.
  • 17
    Tsianos EV, Di Bisceglie AM, Papadopoulos NM, Costello R, Hoofnagle JH. Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis. Am J Gastroenterology 1990; 85: 10051008.
  • 18
    Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 335: 13.
  • 19
    Hoofnagle JH. Delta hepatitis and the hepatitis delta virus. In: SeeffLB, LewisJH, eds. Current perspectives in hepatology. New York: Plenum Publishing Corp., 1989; 4762.